Using genomic assessment, we showed multiple pathway similarities between TNF-Tg mice and patients with connective tissue disease–associated PAH (CTD-PAH) (5), which is the second most common cause of PAH, and a subgroup of patients who have poorer outcomes than those with idiopathic PAH. Here, TNF is linked to pulmonary arterial hypertension.